Technical Analysis for BLUE - bluebird bio, Inc.

Grade Last Price % Change Price Change
grade D 170.5 0.00% 0.00
BLUE closed unchanged on Friday, April 20, 2018, on 60 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Earnings due: May 2

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Down
See historical BLUE trend table...

Date Alert Name Type % Chg
Apr 20 Narrow Range Bar Range Contraction 0.00%
Apr 20 NR7 Range Contraction 0.00%
Apr 20 Multiple of Ten Bullish Other 0.00%
Apr 19 Multiple of Ten Bullish Other 0.00%
Apr 19 Outside Day Range Expansion 0.00%
Apr 18 NR7 Range Contraction -2.43%
Apr 18 NR7-2 Range Contraction -2.43%
Apr 17 Hammer Candlestick Bullish -0.32%
Apr 17 NR7 Range Contraction -0.32%
Apr 17 Doji - Bullish? Reversal -0.32%

Older signals for BLUE ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
bluebird bio, Inc., a clinical-stage biotechnology company, focuses on the development, manufacture, and marketing of therapies to treat various human diseases. Its product candidates include Lenti-D to treat patients with childhood cerebral adrenoleukodystrophy (ALD), a hereditary neurological disorder, as well as for the treatment of adult cerebral ALD; and CAR T cells products for treating oncology diseases. The company's product candidates also comprise LentiGlobin vector for the treatment of ß-thalassemia, a hereditary blood disorder; and sickle cell diseases. It has a strategic collaboration with Celgene Corporation to discover, develop, and commercialize disease-altering gene therapies in oncology. The company was formerly known as Genetix Pharmaceuticals, Inc., and changed its name to bluebird bio, Inc. in September 2010. bluebird bio, Inc. was founded in 1992 and is headquartered in Cambridge, Massachusetts.
Is BLUE a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 236.17
52 Week Low 74.45
Average Volume 775,983
200-Day Moving Average 154.9709
50-Day Moving Average 193.14
20-Day Moving Average 172.7025
10-Day Moving Average 173.01
Average True Range 9.3645
ADX 23.47
+DI 19.78
-DI 25.81
Chandelier Exit (Long, 3 ATRs ) 167.6565
Chandelier Exit (Short, 3 ATRs ) 182.5435
Upper Bollinger Band 186.6845
Lower Bollinger Band 158.7205
Percent B (%b) 0.42
BandWidth 16.192006
MACD Line -6.1025
MACD Signal Line -7.2041
MACD Histogram 1.1016
Fundamentals Value
Market Cap 7.77 Billion
Num Shares 45.6 Million
EPS -7.33
Price-to-Earnings (P/E) Ratio -23.26
Price-to-Sales 233.66
Price-to-Book 5.18
PEG Ratio 0.31
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 177.48
Resistance 3 (R3) 177.48 175.17 176.31
Resistance 2 (R2) 175.17 173.39 175.16 175.92
Resistance 1 (R1) 172.83 172.29 172.83 172.83 175.54
Pivot Point 170.52 170.52 170.51 170.51 170.52
Support 1 (S1) 168.18 168.74 168.18 168.18 165.46
Support 2 (S2) 165.87 167.64 165.86 165.08
Support 3 (S3) 163.53 165.87 164.69
Support 4 (S4) 163.53